6. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, Benda J, Cella D: Phase III trial of four cisplatin- containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study . J Clin Oncol 2009, 27(28):4649-4655. 7. Tewari KS, Sill MW, Long HJ, 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM et al : Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014, 370(8):734-743. 8. Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD: Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2009, 27(7):1069-1074.